What Has Been the Growth of the Enzyme Linked Immunosorbent Assay Testing Market So Far?
The enzyme linked immunosorbent assay testing market has seen considerable growth due to a variety of factors.
• In recent times, there has been notable growth in the market size of enzyme-linked immunosorbent assay testing. There's an expected increase from $2.85 billion in 2024 to $3.04 billion in 2025, showing a compound annual growth rate (CAGR) of 6.7%.
This uptick during the historic period can be accounted for by factors such as the widespread of chronic diseases, increased financial backing and focus on biomedical research, approval of ELISA tests by regulatory bodies, governmental support, and health awareness initiatives.
How Will the Enzyme Linked Immunosorbent Assay Testing Market?
The enzyme linked immunosorbent assay testing market is expected to maintain its strong growth trajectory in upcoming years.
• The market for enzyme-linked immunosorbent assay testing is anticipated to experience significant expansion in the coming years. The projected growth is estimated to reach $3.88 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%.
The boom during this outlook time frame is credited to the surging need for personalized medication, an increasing elderly population, a driven focus towards earlier diagnosis, better healthcare availability, and an escalating demand for long-term disease supervision. The forecast period is marked by pivotal developments such as tech advancements, increased enthusiasm for point-of-care testing, the widening scope of applications, the implementation of high-throughput screening, and the advent of digital ELISA.
Which Factors Are Boosting Growth In The Enzyme Linked Immunosorbent Assay Testing Market?
The rise in infectious diseases is predicted to fuel the enzyme-linked immunosorbent assay testing market's advancement. Infectious diseases result from harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can transmit among people and affect numerous body systems. The escalating frequency of these diseases can be linked to increased global travel and the emergence of antimicrobial resistance that complicates infection management. Enzyme-linked immunosorbent assay (ELISA) testing proves beneficial for infectious diseases as it precisely detects and quantifies specific antigens or antibodies related to the infection, aiding in diagnosis, tracking disease progression, and appraising treatment effectiveness. For example, data released by the World Health Organization in February 2024, a public health organization based in Switzerland, reported a total of 58114 measles cases (a highly contagious viral infection) in the European Region in 2023, a significant increase from the 941 cases in 2022. Consequently, the escalating frequency of infectious diseases is propelling the growth of the enzyme-linked immunosorbent assay testing market.
What Key Areas Define The Segmentation Of The Global Enzyme Linked Immunosorbent Assay Testing Market?
The enzyme-linked immunosorbent assay testingmarket covered in this report is segmented –
1) By Type: Direct Enzyme-Linked Immunosorbent Assay (ELISA), Sandwich Enzyme-Linked Immunosorbent Assay (ELISA), Indirect Enzyme-Linked Immunosorbent Assay (ELISA), Multiple And Portable Enzyme-Linked Immunosorbent Assay (ELISA), Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Application: Immunology, Inflammation, Infectious Diseases, Cancer, Protein Quantitation, Other Applications
3) By End-User: Hospitals And Diagnostic Centers, Research Laboratories, Other End-Users
Subsegments:
1) By Direct Enzyme-Linked Immunosorbent Assay (ELISA): Single-Step Direct ELISA, Competitive Direct ELISA, Quantitative Direct ELISA, Qualitative Direct ELISA
2) By Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): Two-Step Sandwich ELISA, One-Step Sandwich ELISA, Quantitative Sandwich ELISA, Qualitative Sandwich ELISA
3) By Indirect Enzyme-Linked Immunosorbent Assay (ELISA): Standard Indirect ELISA, Competitive Indirect ELISA, Quantitative Indirect ELISA, Qualitative Indirect ELISA
Pre-Book The Enzyme Linked Immunosorbent Assay Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Enzyme Linked Immunosorbent Assay Testing Market?
Leading firms in the enzyme-linked immunosorbent assay testing market are expanding their portfolio through groundbreaking product innovations such as advanced ELISA kits in an effort to improve diagnostic precision and cater to various research and clinical requirements. These innovative Enzyme-Linked Immunosorbent Assay (ELISA) kits are evolved versions of traditional ELISA tests that provide enhanced precision, sensitivity, and ease of use in the detection and quantification of biomarkers. For example, in February 2023, the American pharmaceutical firm, Charles River Laboratories, introduced a state-of-the-art ELISA kit designed for the detection and measurement of residual host cell proteins (HCP) in CHO-based biotherapeutics. This avant-garde kit uses avian immunoglobulin Y (IgY) antibodies from specific pathogen-free (SPF) chicken eggs, offering improved sensitivity and specificity with detection limits as minute as 0.1 ng/mL and 90% antibody coverage. This introduction aims to enhance quality control in the development of biopharmaceuticals, ensuring the safety and effectiveness of new therapies while offering flexibility to clients to use either on their own or with guidance from Charles River's specialists.
Who Are the Key Players In The Enzyme Linked Immunosorbent Assay Testing Market?
Major companies operating in the enzyme-linked immunosorbent assay testing market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Siemens Healthineers
• Becton Dickinson and Company
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Tecan Group Ltd.
• GenScript Biotech Corporation
• Promega Corporation
• Abcam plc
• R&D Systems Inc.
• Sino Biological Inc.
• OriGene Technologies Inc.
• RayBiotech Inc.
• Santa Cruz Biotechnology Inc.
• AnaSpec Inc.
• Biomatik
• Arigo Biolaboratories Corp.
• MyBioSource Inc.
• Boster Biological Technology
• Eagle Biosciences Inc.
• Enzo Life Sciences Inc.
• StressMarq Biosciences Inc.
• XpressBio
What Is The Most Dominant Region In The Enzyme Linked Immunosorbent Assay Testing Market?
North America was the largest region in the enzyme-linked immunosorbent assay testing market in 2024. The regions covered in the enzyme-linked immunosorbent assay testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
